Summary
51 / 100 · Bulios Score
What speaks for it
- Revenue grew by 43% a year over the last 3 years.
- It holds more cash than debt: $291.4M against $69.5M.
- Analysts expect revenue to grow by 28% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- Out of every 100 USD of revenue, only 4.9 USD is left as net profit.
- It earns only 0.9 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 271.3 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 60% a year over 5 years. Over the last 3 years it grew by 43% a year. For the next fiscal year analysts expect revenue to grow by 28%.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 24 USD
- Research and development 20 USD
- Sales and administration 55 USD
- Taxes and other -3.9 USD
- Net profit 4.9 USD
Net profit, industry median (Software - Infrastructure) 8.4 USD
Out of every 100 USD of revenue, 4.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 15
- Hold 5
- Sell 0
Today's price within the analysts' price targets
The average target of $51.15 is 29% above today's price. 75% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Subscription and Circulation 98%
- Product and Service, Other 1.9%
By region
- UNITED STATES 86%
- Non-US 14%
Subscription and Circulation brings in 98% of revenue.
Segments in detail